<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>cholestyramine</title><link>http://www.unboundmedicine.com/medline/ebm/research/cholestyramine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Chronic Radiation Enteritis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19897345/full_citation/Chronic_Radiation_Enteritis_</link><description>Theis VS, Sripadam R, Ramani V, et al. <br/><span class="title">Chronic Radiation Enteritis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical oncology (Royal College of Radiologists (Great Britain))">Clin Oncol (R Coll Radiol) 2009 Nov 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19897345/abstract/Chronic_Radiation_Enteritis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19897345/full_citation/Chronic_Radiation_Enteritis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19897345/Chronic_Radiation_Enteritis_">Find Related Articles</a> </description></item><item><title>A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19705923/full_citation/A_quantitative_enterohepatic_circulation_model:_development_and_evaluation_with_tesofensine_and_meloxicam_</link><description>Lehr T, Staab A, Tillmann C, et al. <br/><span class="title">A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Clinical pharmacokinetics">Clin Pharmacokinet 2009; 48(8):529-42.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19705923/abstract/A_quantitative_enterohepatic_circulation_model:_development_and_evaluation_with_tesofensine_and_meloxicam_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19705923/full_citation/A_quantitative_enterohepatic_circulation_model:_development_and_evaluation_with_tesofensine_and_meloxicam_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0312-5963%26amp;volume=48%26amp;issue=8%26amp;spage=529">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19705923/A_quantitative_enterohepatic_circulation_model:_development_and_evaluation_with_tesofensine_and_meloxicam_">Find Related Articles</a> </description></item><item><title>Combined therapy in the treatment of dyslipidemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19682080/full_citation/Combined_therapy_in_the_treatment_of_dyslipidemia_</link><description>Reiner Z <br/><span class="title">Combined therapy in the treatment of dyslipidemia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Fundamental &amp; clinical pharmacology">Fundam Clin Pharmacol 2009 Aug 14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19682080/abstract/Combined_therapy_in_the_treatment_of_dyslipidemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19682080/full_citation/Combined_therapy_in_the_treatment_of_dyslipidemia_">Full Citation</a></description></item><item><title>Gene-activators Prevent and Regress Atherosclerosis and Reduce Mortality.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19607643/full_citation/Gene_activators_Prevent_and_Regress_Atherosclerosis_and_Reduce_Mortality_</link><description>Luoma P <br/><span class="title">Gene-activators Prevent and Regress Atherosclerosis and Reduce Mortality. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cardiovascular &amp; hematological agents in medicinal chemistry">Cardiovasc Hematol Agents Med Chem 2009 Oct 1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19607643/abstract/Gene_activators_Prevent_and_Regress_Atherosclerosis_and_Reduce_Mortality_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19607643/full_citation/Gene_activators_Prevent_and_Regress_Atherosclerosis_and_Reduce_Mortality_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19607643/Gene_activators_Prevent_and_Regress_Atherosclerosis_and_Reduce_Mortality_">Find Related Articles</a> </description></item><item><title>Bile acid-binding activity of young persimmon (Diospyros kaki) fruit and its hypolipidemic effect in mice.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19585467/full_citation/Bile_acid_binding_activity_of_young_persimmon__Diospyros_kaki__fruit_and_its_hypolipidemic_effect_in_mice_</link><description>Matsumoto K, Yokoyama SI, Gato N <br/><span class="title">Bile acid-binding activity of young persimmon (Diospyros kaki) fruit and its hypolipidemic effect in mice. [JOURNAL ARTICLE]</span><br/><span class="source" title="Phytotherapy research : PTR">Phytother Res 2009 Jul 7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19585467/abstract/Bile_acid_binding_activity_of_young_persimmon__Diospyros_kaki__fruit_and_its_hypolipidemic_effect_in_mice_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19585467/full_citation/Bile_acid_binding_activity_of_young_persimmon__Diospyros_kaki__fruit_and_its_hypolipidemic_effect_in_mice_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19585467/Bile_acid_binding_activity_of_young_persimmon__Diospyros_kaki__fruit_and_its_hypolipidemic_effect_in_mice_">Find Related Articles</a> </description></item><item><title>Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19537927/full_citation/Regulation_of_diurnal_variation_of_cholesterol_7alpha_hydroxylase__CYP7A1__activity_in_healthy_subjects_</link><description>Kovář J, Leníček V, Zimolová M, et al. <br/><span class="title">Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects. [JOURNAL ARTICLE]</span><br/><span class="source" title="Physiological research / Academia Scientiarum Bohemoslovaca">Physiol Res 2009 Jun 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19537927/abstract/Regulation_of_diurnal_variation_of_cholesterol_7alpha_hydroxylase__CYP7A1__activity_in_healthy_subjects_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19537927/full_citation/Regulation_of_diurnal_variation_of_cholesterol_7alpha_hydroxylase__CYP7A1__activity_in_healthy_subjects_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19537927/Regulation_of_diurnal_variation_of_cholesterol_7alpha_hydroxylase__CYP7A1__activity_in_healthy_subjects_">Find Related Articles</a> </description></item><item><title>Hepatotoxicity Induced by Methimazole in a Previously Health Patient.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19534646/full_citation/Hepatotoxicity_Induced_by_Methimazole_in_a_Previously_Health_Patient_</link><description>Luca G, Orietta S, Caterina P, et al. <br/><span class="title">Hepatotoxicity Induced by Methimazole in a Previously Health Patient. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current drug safety">Curr Drug Saf 2009 Sep 1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19534646/abstract/Hepatotoxicity_Induced_by_Methimazole_in_a_Previously_Health_Patient_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19534646/full_citation/Hepatotoxicity_Induced_by_Methimazole_in_a_Previously_Health_Patient_">Full Citation</a></description></item><item><title>Leflunomide-induced polymyositis in a patient with rheumatoid arthritis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19526307/full_citation/Leflunomide_induced_polymyositis_in_a_patient_with_rheumatoid_arthritis_</link><description>Ochi S, Taniguchi K, Nagashima M <br/><span class="title">Leflunomide-induced polymyositis in a patient with rheumatoid arthritis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Modern rheumatology / the Japan Rheumatism Association">Mod Rheumatol 2009 Jun 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19526307/abstract/Leflunomide_induced_polymyositis_in_a_patient_with_rheumatoid_arthritis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19526307/full_citation/Leflunomide_induced_polymyositis_in_a_patient_with_rheumatoid_arthritis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19526307/Leflunomide_induced_polymyositis_in_a_patient_with_rheumatoid_arthritis_">Find Related Articles</a> </description></item><item><title>In Vitro and In Vivo Studies on Chitosan Beads of Losartan Duolite AP143 Complex, Optimized by Using Statistical Experimental Design.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19495989/full_citation/In_Vitro_and_In_Vivo_Studies_on_Chitosan_Beads_of_Losartan_Duolite_AP143_Complex_Optimized_by_Using_Statistical_Experimental_Design_</link><description>Madgulkar A, Bhalekar M, Swami M <br/><span class="title">In Vitro and In Vivo Studies on Chitosan Beads of Losartan Duolite AP143 Complex, Optimized by Using Statistical Experimental Design. [JOURNAL ARTICLE]</span><br/><span class="source" title="AAPS PharmSciTech">AAPS PharmSciTech 2009 Jun 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19495989/abstract/In_Vitro_and_In_Vivo_Studies_on_Chitosan_Beads_of_Losartan_Duolite_AP143_Complex_Optimized_by_Using_Statistical_Experimental_Design_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19495989/full_citation/In_Vitro_and_In_Vivo_Studies_on_Chitosan_Beads_of_Losartan_Duolite_AP143_Complex_Optimized_by_Using_Statistical_Experimental_Design_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19495989/In_Vitro_and_In_Vivo_Studies_on_Chitosan_Beads_of_Losartan_Duolite_AP143_Complex_Optimized_by_Using_Statistical_Experimental_Design_">Find Related Articles</a> </description></item><item><title>Protection of live bacteria from bile acid toxicity using bile acid adsorbing resins.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19490986/full_citation/Protection_of_live_bacteria_from_bile_acid_toxicity_using_bile_acid_adsorbing_resins_</link><description>Edwards AD, Slater NK <br/><span class="title">Protection of live bacteria from bile acid toxicity using bile acid adsorbing resins. [Journal Article]</span><br/><span class="source" title="Vaccine">Vaccine 2009 Jun 12; 27(29):3897-903.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19490986/abstract/Protection_of_live_bacteria_from_bile_acid_toxicity_using_bile_acid_adsorbing_resins_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19490986/full_citation/Protection_of_live_bacteria_from_bile_acid_toxicity_using_bile_acid_adsorbing_resins_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19490986/Protection_of_live_bacteria_from_bile_acid_toxicity_using_bile_acid_adsorbing_resins_">Find Related Articles</a> </description></item></channel></rss>